ArticleScientific reports2026
WTAM-YOLO: a YOLOv11-based method for pulmonary nodule detection.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Inter-Slice Representation Outweighs Bounding-Box Supervision Extent in Lightweight 2.5D Pulmonary Nodule Detection: A Whole-Volume Benchmark on LUNA16.Diagnostics (Basel, Switzerland) · 2026Article
- Anatomical-Contextual YOLOv8-YOLOv12 Framework for Pulmonary Nodule Detection in CT: Multi-Organ Learning and Cross-Dataset Validation.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Lung cancer is among the malignancies with the highest incidence and mortality rates worldwide, and it poses a serious threat to human health. Increasing the accuracy of pulmonary nodule detection in CT images is essential for the early diagnosis and treatment of lung cancer. However, the grayscale characteristics of lung CT images, together with the variability in the sizes and morphologies of nodules, make the existing detection models prone to false positives and false negatives, posing challenges for achieving accurate detection. To address these problems, an improved WTAM-YOLO model based on YOLOv11 is proposed in this study. The model features four main improvements: a wavelet convolution approach to expand the receptive field, a lightweight convolutional block attention module (CBAM) to enhance the key feature representations, a hierarchical residual attention mixer (HRAMi) module to improve the multiscale detection performance of the model, and an improved exponential moving average (iEMA) module to strengthen the detail capture ability of the model and reduce the number of false positives. Experiments are conducted with a pulmonary nodule dataset acquired from the Roboflow platform and the LUNA16 dataset. Compared with those of YOLOv11, the proposed model improves the mAP@50 values by 3.4% and 2.5%, the mAP@75 values by 9.5% and 7.0%, the precision values by 4.4% and 0.7%, and the recall values by 2.3% and 4.6% based on the Roboflow and LUNA16 datasets, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.